UM  > 健康科學學院
Adjunctive minocycline for schizophrenia: A meta-analysis of randomized controlled trials
Xiang, Ying-Qiang1,2; Zheng, Wei3; Wang, Shi-Bin4; Yang, Xin-Hu3; Cai, Dong-Bin5; Ng, Chee H.6; Ungvari, Gabor S.7,8; Kelly, Deanna L.9; Xu, Wei-Ying10; Xiang, Yu-Tao4
2017-01
Source PublicationEUROPEAN NEUROPSYCHOPHARMACOLOGY
ISSN0924-977X
Volume27Issue:1Pages:8-18
Abstract

This study aimed to conduct a meta-analysis of the efficacy and safety of adjunctive minocycline for schizophrenia. Randomized controlled trials (RCTs) comparing adjunctive minocycline with placebo in patients with schizophrenia were included in the meta-analysis. Two independent investigators extracted and synthesized data. Standard mean differences (SMDs), risk ratio (RR) +/- 95% confidence intervals (CIs) and the number-needed-to-harm (NNH) were calculated. Eight RCTs with 548 schizophrenia patient including 286 (52.2%) patients on minocycline (171.9 +/- 31.2 mg/day) and 262 (47.8%) on placebo completed 18.5 +/- 13.4 weeks of treatment. Meta-analyses of Positive and Negative Syndrome Scale (PANSS) (7 RCTs with 8 treatment arms)/Brief Psychiatric Rating Scale (BPRS) (1 RCT) total score [SMD: -0.64, (95% CI: -1.02, -0.27), P=0.0008; l(2)=74%], positive, negative and general symptom scores [SMD: -0.69 to -0.22 (95%CI: -0.98, -0.03), P=0.02-0.00001; l(2)=7-63%] revealed a significant superiority of adjunctive minocycline treatment over the placebo. There was no significant difference regarding neurocognitive function, discontinuation rate and adverse drug reactions between the two groups. This meta-analysis showed that adjunctive minocycline appears to be efficacious and safe for schizophrenia. Due to significant heterogeneity, future studies with a large sample size are needed to confirm these findings. (C) 2016 Elsevier B.V. and ECNP. All rights reserved.

KeywordSchizophrenia Minocycline Antipsychotic Meta-analysis
DOIhttp://doi.org/10.1016/j.euroneuro.2016.11.012
URLView the original
Indexed BySCI ; SSCI ; SSCI
Language英语
WOS Research AreaNeurosciences & Neurology ; Pharmacology & Pharmacy ; Psychiatry
WOS SubjectClinical Neurology ; Neurosciences ; Pharmacology & Pharmacy ; Psychiatry
WOS IDWOS:000393244500002
PublisherELSEVIER SCIENCE BV
The Source to ArticleWOS
Fulltext Access
Citation statistics
Cited Times [WOS]:24   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionFaculty of Health Sciences
Corresponding AuthorZheng, Wei; Xiang, Yu-Tao
Affiliation1.National Clinical Research Center for Mental Disorders, Beijing, China & Center of Depression, Beijing Institute for Brain Disorders, China
2.Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China
3.The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China
4.Unit of Psychiatry, Faculty of Health Sciences, University of Macau, Macao
5.Faculty of Traditional Chinese Medicine, the First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China
6.Department of Psychiatry, University of Melbourne, Melbourne, Victoria, Australia
7.The University of Notre Dame Australia/Marian Centre, Perth, Australia
8.School of Psychiatry & Clinical Neurosciences, University of Western Australia, Perth, Australia
9.Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA
10.The Affiliated Hospital of JiangXi University of Traditional Chinese Medicine, Nanchang, China
Corresponding Author AffilicationFaculty of Health Sciences
Recommended Citation
GB/T 7714
Xiang, Ying-Qiang,Zheng, Wei,Wang, Shi-Bin,et al. Adjunctive minocycline for schizophrenia: A meta-analysis of randomized controlled trials[J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY,2017,27(1):8-18.
APA Xiang, Ying-Qiang.,Zheng, Wei.,Wang, Shi-Bin.,Yang, Xin-Hu.,Cai, Dong-Bin.,...&Xiang, Yu-Tao.(2017).Adjunctive minocycline for schizophrenia: A meta-analysis of randomized controlled trials.EUROPEAN NEUROPSYCHOPHARMACOLOGY,27(1),8-18.
MLA Xiang, Ying-Qiang,et al."Adjunctive minocycline for schizophrenia: A meta-analysis of randomized controlled trials".EUROPEAN NEUROPSYCHOPHARMACOLOGY 27.1(2017):8-18.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Xiang, Ying-Qiang]'s Articles
[Zheng, Wei]'s Articles
[Wang, Shi-Bin]'s Articles
Baidu academic
Similar articles in Baidu academic
[Xiang, Ying-Qiang]'s Articles
[Zheng, Wei]'s Articles
[Wang, Shi-Bin]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Xiang, Ying-Qiang]'s Articles
[Zheng, Wei]'s Articles
[Wang, Shi-Bin]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.